Odyssey Health, Inc.
ODYY · OTCMCIK 1626644fmd_0QP9XH2H2GVXM7RF17TZZPTD72Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Aug 01, 2014 to Jul 31, 2026, 48 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Cost of revenue | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Gross profit | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Realized investment gains (losses) | – | – | – | – | – | – | – | (2) | (0) | 0 |
| Research and development | – | – | 23 | 0 | 2 | – | 0 | 0 | 0 | 0 |
| Operating income | (0) | (0) | (24) | (4) | (16) | (8) | (5) | (2) | (1) | (1) |
| Interest expense | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 2 |
| Other non-operating income (expense) | – | – | – | – | – | – | 0 | 0 | (0) | (0) |
| Income tax expense | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | (0) | (0) | (23) | (4) | (17) | (8) | (6) | (1) | (2) | (6) |
| Net income to common shareholders | – | – | – | – | – | – | (6) | (1) | (2) | – |